Metabolic Reprogramming of Leukemia Stem Cells as a Novel Therapeutic Target for Relapsed Acute Myeloid Leukemia. Pjmcr [Internet]. 2026 Mar. 25 [cited 2026 Sep. 1];5(1):5786-812. Available from: https://pakjmcr.com/index.php/1/article/view/1698